Have a feature idea you'd love to see implemented?
Let us know!
RCEL AVITA Medical Inc
Price (delayed)
$9
Market cap
$235.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.23
Enterprise value
$262.95M
AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection
Highlights
The gross profit has grown by 27% year-on-year and by 10% since the previous quarter
The revenue has grown by 26% YoY and by 10% from the previous quarter
AVITA Medical's equity has shrunk by 81% YoY and by 49% QoQ
The net income has plunged by 70% YoY and by 15% from the previous quarter
Key stats
What are the main financial stats of RCEL
Market
Valuations
Earnings
Shares outstanding
26.22M
Market cap
$235.96M
Enterprise value
$262.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
19.13
Price to sales (P/S)
3.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.38
Revenue
$60.1M
Gross profit
$51.49M
Net income
-$57.32M
EBIT
-$52.09M
EBITDA
-$50.34M
Free cash flow
-$59.58M
Per share
Balance sheet
Liquidity
EPS
-$2.23
EPS diluted
-$2.23
Free cash flow per share
-$2.29
Book value per share
$0.47
Revenue per share
$2.31
TBVPS
$3.1
Total assets
$81.05M
Total liabilities
$68.6M
Debt
$45.63M
Equity
$12.23M
Working capital
$46.78M
Debt to equity
3.73
Current ratio
3.73
Quick ratio
3.2
Net debt/EBITDA
-0.54
Margins
Efficiency
Dividend
EBITDA margin
-83.8%
Gross margin
85.7%
Net margin
-95.4%
Operating margin
-98%
Return on assets
-60.7%
Return on equity
-194.7%
Return on invested capital
-49.6%
Return on capital employed
-81.5%
Return on sales
-86.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RCEL stock price
How has the AVITA Medical stock price performed over time
Intraday
1.24%
1 week
0.67%
1 month
-26.29%
1 year
-38.23%
YTD
-29.69%
QTD
-29.69%
Financial performance
How have AVITA Medical's revenue and profit performed over time
Revenue
$60.1M
Gross profit
$51.49M
Operating income
-$58.91M
Net income
-$57.32M
Gross margin
85.7%
Net margin
-95.4%
The net income has plunged by 70% YoY and by 15% from the previous quarter
The operating income has plunged by 62% YoY and by 8% from the previous quarter
RCEL's net margin is down by 36% year-on-year and by 4.1% since the previous quarter
RCEL's operating margin is down by 29% YoY but it is up by 2% from the previous quarter
Growth
What is AVITA Medical's growth rate over time
Valuation
What is AVITA Medical stock price valuation
P/E
N/A
P/B
19.13
P/S
3.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.38
The company's EPS has shrunk by 66% YoY and by 14% QoQ
AVITA Medical's equity has shrunk by 81% YoY and by 49% QoQ
The stock's price to book (P/B) is 48% more than its last 4 quarters average of 12.8
The P/S is 67% below the 5-year quarterly average of 11.5 and 34% below the last 4 quarters average of 5.8
The revenue has grown by 26% YoY and by 10% from the previous quarter
Efficiency
How efficient is AVITA Medical business performance
AVITA Medical's return on equity has shrunk by 65% QoQ
The return on assets has dropped by 61% year-on-year and by 15% since the previous quarter
The ROIC has grown by 34% YoY and by 6% from the previous quarter
The company's return on sales fell by 24% YoY and by 2.7% QoQ
Dividends
What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RCEL.
Financial health
How did AVITA Medical financials performed over time
The total assets is 18% greater than the total liabilities
RCEL's quick ratio is down by 43% year-on-year and by 30% since the previous quarter
AVITA Medical's current ratio has decreased by 40% YoY and by 29% QoQ
RCEL's debt to equity has soared by 102% since the previous quarter
AVITA Medical's equity has shrunk by 81% YoY and by 49% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.